Pauwels Eric's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Jan 12, 2026
- Accession no.
- 0001323212-26-000006
- Filed
- Jan 12, 2026
- Trade date
- Jan 8-12, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions. Open-market sales total $565.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pauwels EricCIK 0001323212 | Officer (CHIEF BUSINESS OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Common Stock | SSaleDisposed | −2,561 | $76.42F2 | −$195,711.62 | 84,928 | Direct | |
| Jan 8, 2026 | Common Stock | SSaleDisposed | −587 | $76.98F3 | −$45,187.26 | 84,341 | Direct | |
| Jan 8, 2026 | Common Stock | SSaleDisposed | −1,454 | $76.45 | −$111,158.3 | 82,887 | Direct | |
| Jan 9, 2026 | Common Stock | SSaleDisposed | −1,722 | $77.41F5 | −$133,300.02 | 81,165 | Direct | |
| Jan 12, 2026 | Common Stock | SSaleDisposed | −1,024 | $78.70F6 | −$80,588.8 | 80,141 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.89 to $76.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.91 to $77.13 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.10 to $77.77 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.16 to $79.01 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.